Rheumatology
1001 – 1010 of 1561
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Long-term follow-up of RA patients of the Hellenic Biologics Registry: comparison of first versus second anti-TNF-alpha therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
From aggrecan to matrix
2009) Annual General Meeting of the British-Society-for-Matrix-Biology In International Journal of Experimental Pathology 90(2). p.93-93(
- Contribution to journal › Published meeting abstract
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Very Early Intervention Is Crucial to Improve Work Outcome in Patients with Rheumatoid Arthritis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Distinct Temporal Evolution of TLR-mediated Dendritic Cell Cytokine Secretion in Patients with Limitied and Diffuse Cutaneous Systemic Sclerosis
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.153-154(
- Contribution to journal › Published meeting abstract
-
Mark
The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)
(
- Contribution to journal › Article
-
Mark
The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGF beta and IFN gamma Distinguishes Different SSc Clinical Phenotypes
2009) 9th Annual Meeting of the Federation-of-Clinical-Immunology-Societies In Clinical Immunology 131. p.124-125(
- Contribution to journal › Published meeting abstract
-
Mark
Correlation of in-vivo fragmentation of fibromodulin with that generated in-vitro by MMP-13 and ADAMTS-4 but not ADAMTS-5
2009) Annual General Meeting of the British-Society-for-Matrix-Biology In International Journal of Experimental Pathology 90(2). p.99-99(
- Contribution to journal › Published meeting abstract
-
Mark
Limitations of Antinuclear Antibody Tests (HEp-2) Are Overcome with the Autoimmune Target Test (IT-1) in Systemic Lupus Erythematosus Reply
(
- Contribution to journal › Letter
-
Mark
Geriatric rheumatoid arthritis patients on delayed anti-TF-alpha agents have higher disease activity and experience more often serious adverse events compared to younger adults
(
- Contribution to journal › Published meeting abstract